With his nomination, Prof. Camilo Perez joins a high-ranking network of 73 current and 384 former EMBO Young Investigators , who represent some of the best young scientists in Europe and beyond. Established in 2000, the EMBO…
The brain is our body’s most complex organ and consists of about 100 billion neurons. For the error-free transmission of information and for proper functioning, the different cells must be programmed in a way that they…
“We are very pleased to be joined by two experienced and specialised investors, the Boehringer Ingelheim Venture Fund and Reference Capital SA. This is optimal for completing preclinical work, and for planning and conducting…
Cancer cells are characterized by uncontrolled growth and cell division. A glioblastoma is a particularly aggressive form of brain tumor, which results from uncontrolled growth of so-called glial cells. Glial cells surround…
The structure of a protein reveals a lot about its function. This means, the more precisely the three-dimensional protein structure is known, the better the conclusions on its function can be drawn. Using NMR spectroscopy,…
In Europe alone, hundreds of different variants of the new coronavirus SARS-CoV-2 are currently circulating, distinguished by mutations in their genomes. However, only very few of these variants have spread as successfully…
Each year, EMBO selects some of the very best junior life science researchers in Europe to join the Young Investigator Program. With her nomination, Dr. Claudia Keller Valsecchi becomes a member of a high-ranking network of…
Diabetes is a medical condition in which the body is unable to keep blood sugar in a healthy range. Normally, the pancreas produces sufficient insulin to regulate the blood sugar level and maintain homeostasis. However, in…
ARTIDIS AG announced the successful completion of its clinical study “NANO”, which was performed to evaluate the utility and the sensitivity of a nanomechanical biomarker, developed by ARTIDIS, for breast cancer diagnosis.…
T3 Pharmaceuticals is one of top five startup companies selected by the W.A. de Vigier Foundation. The winning companies were selected from a record number of 256 applications in a multi-step process. At the award ceremony…
This website uses cookies to collect data from users and improve functionality. By continuing to browse the site you are agreeing to this. Receive more information by reading our privacy policy.
